Advertisement
U.S. markets open in 23 minutes
  • S&P Futures

    5,308.00
    -0.25 (-0.00%)
     
  • Dow Futures

    40,180.00
    +36.00 (+0.09%)
     
  • Nasdaq Futures

    18,494.00
    -9.75 (-0.05%)
     
  • Russell 2000 Futures

    2,142.40
    +4.00 (+0.19%)
     
  • Crude Oil

    82.68
    +1.33 (+1.63%)
     
  • Gold

    2,234.10
    +21.40 (+0.97%)
     
  • Silver

    24.80
    +0.04 (+0.17%)
     
  • EUR/USD

    1.0818
    -0.0012 (-0.11%)
     
  • 10-Yr Bond

    4.2120
    +0.0160 (+0.38%)
     
  • Vix

    12.97
    +0.19 (+1.49%)
     
  • GBP/USD

    1.2645
    +0.0007 (+0.06%)
     
  • USD/JPY

    151.2180
    -0.0280 (-0.02%)
     
  • Bitcoin USD

    70,781.17
    -69.73 (-0.10%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,957.18
    +25.20 (+0.32%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Today's Research Reports on Trending Tickers: Novavax and Allogene Therapeutics

NEW YORK, NY / ACCESSWIRE / January 14, 2019 /U.S. equities posted strong weekly gains, however, stock closed lower for the day on Friday on concerns over an ongoing U.S. government shutdown and worries about an economic slowdown in China. The Dow Jones Industrial Average dropped marginally by 0.02 percent to close 23,995.95, and S&P 500 was down by just 0.01 percent to settle at 2,596.64. The Nasdaq dropped 0.21 percent to close at 6,971.48. For the week, both Dow Jones Industrial Average and S&P 500 gained more than 2 percent and the Nasdaq Composite jumped 3.45 percent.

Joseph Song, an economist at Bank of America Merrill Lynch, said in a note to clients, "We think a deal will be reached to reopen the government, but only after economic, financial and/or political pain is felt," he added, "Every two weeks of a shutdown trims 0.1 [percentage points] from growth; additional drag is likely due to delays in spending and investment."

The Market Edge Initiates Coverage on:

Novavax, Inc.
https://marketedgereport.com/report/NVAX/

Allogene Therapeutics, Inc.
https://marketedgereport.com/report/ALLO/

Novavax's stock moved 1.35% lower Friday, to close the day at $2.20. The stock recorded a trading volume of 7,776,342 shares, which was below its three months average volume of 7,785,180 shares. In the last year, Novavax's shares have traded in a range of 1.15 - 2.75. The share price has gained 91.3% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.09 is above its 200-day moving average of $1.70. Shares of Novavax have dropped roughly 4.35 percent in the past month and are up 19.57 percent year-to-date.

Access The Market Edge's Novavax, Inc. Research Report:
https://marketedgereport.com/report/NVAX/

On Friday, shares of Allogene Therapeutics recorded a trading volume of 504,717 shares, which was below the three months average volume of 648,624 shares. The stock ended the day 5.02% higher at $29.51. The share price has fallen 16.99% from its 52 week high with a 52 week trading range of 21.67 - 35.55. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $27.11 is above its 200-day moving average of $26.68. Shares of Allogene Therapeutics have gained roughly 12.89 percent in the past month and are up 9.58 percent year-to-date.

Access The Market Edge's Allogene Therapeutics, Inc. Research Report:
https://marketedgereport.com/report/ALLO/

Our Actionable Research on Novavax, Inc. (NASDAQ:NVAX) and Allogene Therapeutics, Inc. (NASDAQ:ALLO) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: MarketEdgeReport

Advertisement